DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market ...
The gross proceeds from the initial public offering are expected to be approximately $191 million, before deducting underwriting discounts and commissions and other offering expenses, and excluding ...
The Bridgewater, N.J., biopharmaceutical company said brensocatib has the potential to become the first and only approved treatment for non-cystic fibrosis bronchiectasis, which causes the lungs' ...
BRIDGEWATER, N.J. - Insmed Incorporated (NASDAQ:INSM), a biopharmaceutical company with a market capitalization of $14.57 ...
The US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for brensocatib for patients with ...
Insmed (INSM) announced that the U.S. FDA has accepted the company’s New Drug Application for brensocatib for patients with non-cystic fibrosis ...
Sionna Therapeutics, Inc SION IPO will take place February, 07 on the NASDAQ exchange under the ticker SION. The company is ...
Lennox, who was diagnosed with cystic fibrosis at 3 weeks old, was invited to morning skate ahead of the Hawks’ night game ...
Cystic fibrosis is a genetic disorder that changes a vital protein in the body, causing a buildup of thick and sticky mucus, ...
Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients ...
Irish Examiner on MSN7h
Storm Éowyn: Hospitals seeing 'social admissions' due to lack of power and water at home, HSE saysHospitals in areas hit by Storm Éowyn are now admitting patients who would normally not need help but have been left ...
Drying wet clothing on racks in poorly ventilated spaces could increase mould growth in a home, which is associated with poor health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback